Belite Bio (BLTE) Institutional Ownership $65.72 +0.71 (+1.09%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$65.16 -0.56 (-0.86%) As of 08/1/2025 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)CurrentInstitutional OwnershipPercentage0.53%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$22.30MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$486.26K Get BLTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLTE Institutional Buying and Selling by Quarter Belite Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/14/2025 GAMMA Investing LLC1,582$91K0.0%-14.4%0.005% 5/16/2025Alyeska Investment Group L.P.83,623$5.54M0.0%N/A0.263% 4/15/2025 GAMMA Investing LLC1,849$122K0.0%+43.3%0.006% 4/7/2025 GAMMA Investing LLC122,441$8.11M0.0%+9,391.6%0.385% 2/17/2025Citadel Advisors LLC5,211$329K0.0%-19.3%0.017% 2/17/2025Bank of America Corp DE18,342$1.16M0.0%+36.4%0.059% 2/17/2025BNP Paribas Financial Markets2,450$155K0.0%N/A0.008% 2/14/2025Virtus ETF Advisers LLC1,122$71K0.0%-39.1%0.004% 2/13/2025Marshall Wace LLP5,865$370K0.0%-30.9%0.018% 2/13/2025XTX Topco Ltd7,062$446K0.0%+30.9%0.022% Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025JPMorgan Chase & Co.14,636$924K0.0%+130.3%0.047% 1/28/2025Advisors Preferred LLC798$52K0.0%N/A0.003% 1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004% 12/26/2024JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021% 11/15/2024XTX Topco Ltd5,394$253K0.0%N/A0.018% 11/15/2024State Street Corp20,086$942K0.0%+28.2%0.066% 11/15/2024Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016% 10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003% 8/19/2024Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025% 8/15/2024Armistice Capital LLC148,000$6.76M0.1%N/A0.497% 2/13/2024Armistice Capital LLC36,000$1.65M0.0%N/A0.130% 2/7/2024Jump Financial LLC5,200$238K0.0%N/A0.019% 11/8/2023 Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272% 8/3/2023 Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268% 2/13/2023 Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264% 11/3/2022Barclays PLC6,661$223K0.0%N/A0.027% 8/15/2022 Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199% (Data available from 1/1/2016 forward) BLTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLTE shares? During the previous two years, 15 institutional investors and hedge funds held shares of Belite Bio. The most heavily invested institutionals were Armistice Capital LLC ($6.76M), Alyeska Investment Group L.P. ($5.54M), Atria Wealth Solutions Inc. ($2.36M), Bank of America Corp DE ($1.16M), State Street Corp ($942K), JPMorgan Chase & Co. ($924K), and XTX Topco Ltd ($446K).Learn more on Belite Bio's institutional investors. What percentage of Belite Bio's stock is owned by institutional investors? 0.53% of Belite Bio's stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings. Which institutional investors have been buying Belite Bio's stock? Of the 11 institutional investors that purchased Belite Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($184K), GAMMA Investing LLC ($122.57K), Alyeska Investment Group L.P. ($83.62K), JPMorgan Chase & Co. ($14.55K), XTX Topco Ltd ($7.06K), Jump Financial LLC ($5.20K), and Bank of America Corp DE ($4.89K). How much institutional buying is happening at Belite Bio? Institutional investors have bought a total of 388,359 shares in the last 24 months. This purchase volume represents approximately $22.30M in transactions. Which of Belite Bio's major shareholders have been selling company stock? The following institutional investors have sold Belite Bio stock in the last 24 months: Point72 Asset Management L.P. ($3.90K), Marshall Wace LLP ($2.62K), Citadel Advisors LLC ($1.25K), Virtus ETF Advisers LLC ($721.00), and GAMMA Investing LLC ($267.00). How much institutional selling is happening at Belite Bio? Institutional investors have sold a total of 8,758 shares in the last 24 months. This volume of shares sold represents approximately $486.26K in transactions. Related Companies LEGN Major Shareholders ELAN Major Shareholders RGC Major Shareholders RVMD Major Shareholders GRFS Major Shareholders TGTX Major Shareholders NUVL Major Shareholders RYTM Major Shareholders CRSP Major Shareholders AXSM Major Shareholders This page (NASDAQ:BLTE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
